Stock BPMC BLUEPRINT MEDICINES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Real-time Estimate Cboe BZX
Other stock markets
 18:36:49 10/05/2024 BST 		5-day change 1st Jan Change
107.1 USD -1.15% Intraday chart for Blueprint Medicines Corporation -0.09% +16.10%
05-06 Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing MT
05-06 Goldman Sachs Adjusts Price Target on Blueprint Medicines to $168 From $121, Maintains Buy Rating MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Blueprint Medicines Corporation, Q1 2024 Earnings Call, May 02, 2024
Transcript : Blueprint Medicines Corporation - Special Call
Transcript : Blueprint Medicines Corporation, Q4 2023 Earnings Call, Feb 15, 2024
Transcript : Blueprint Medicines Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10:30 AM
Transcript : Blueprint Medicines Corporation, Q3 2023 Earnings Call, Oct 26, 2023
Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11:20 AM
Transcript : Blueprint Medicines Corporation, Q2 2023 Earnings Call, Aug 02, 2023
Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 09:20 AM
Transcript : Blueprint Medicines Corporation - Special Call
Transcript : Blueprint Medicines Corporation, Q1 2023 Earnings Call, May 04, 2023
Transcript : Blueprint Medicines Corporation Presents at Barclays Global Healthcare Conference, Mar-15-2023 02:35 PM
Transcript : Blueprint Medicines Corporation - Special Call
Transcript : Blueprint Medicines Corporation, Q4 2022 Earnings Call, Feb 16, 2023
Transcript : Blueprint Medicines Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 04:30 PM
Transcript : Blueprint Medicines Corporation - Analyst/Investor Day
Blueprint Medicines Corporation Provides Revenue Guidance for 2022
CI
Transcript : Blueprint Medicines Corporation - Special Call
Transcript : Blueprint Medicines Corporation, Q2 2022 Earnings Call, Aug 02, 2022
Blueprint Medicines Corporation Provides Revenue Guidance for 2022
CI
Transcript : Blueprint Medicines Corporation - Special Call
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BPMC Stock
  4. News Blueprint Medicines Corporation
  5. Transcripts